Advertisement
Clinical Research and Public HealthIn-Press PreviewEndocrinologyMetabolism
Open Access |
10.1172/JCI207388
1Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, United States of America
2Department of Physiology, Hanyang University, Seoul, Korea, Republic of
3Department of Radiology, Mayo Clinic, Rochester, United States of America
4Department of Quantitative Health Sciences, Mayo Clinic, Rochester, United States of America
5Department of Psychiatry and Psychology, Mayo Clinic, Rochester, United States of America
Find articles by Pataky, M. in: PubMed | Google Scholar
1Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, United States of America
2Department of Physiology, Hanyang University, Seoul, Korea, Republic of
3Department of Radiology, Mayo Clinic, Rochester, United States of America
4Department of Quantitative Health Sciences, Mayo Clinic, Rochester, United States of America
5Department of Psychiatry and Psychology, Mayo Clinic, Rochester, United States of America
Find articles by
Ruegsegger, G.
in:
PubMed
|
Google Scholar
|
1Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, United States of America
2Department of Physiology, Hanyang University, Seoul, Korea, Republic of
3Department of Radiology, Mayo Clinic, Rochester, United States of America
4Department of Quantitative Health Sciences, Mayo Clinic, Rochester, United States of America
5Department of Psychiatry and Psychology, Mayo Clinic, Rochester, United States of America
Find articles by Jo, H. in: PubMed | Google Scholar
1Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, United States of America
2Department of Physiology, Hanyang University, Seoul, Korea, Republic of
3Department of Radiology, Mayo Clinic, Rochester, United States of America
4Department of Quantitative Health Sciences, Mayo Clinic, Rochester, United States of America
5Department of Psychiatry and Psychology, Mayo Clinic, Rochester, United States of America
Find articles by Klaus, K. in: PubMed | Google Scholar
1Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, United States of America
2Department of Physiology, Hanyang University, Seoul, Korea, Republic of
3Department of Radiology, Mayo Clinic, Rochester, United States of America
4Department of Quantitative Health Sciences, Mayo Clinic, Rochester, United States of America
5Department of Psychiatry and Psychology, Mayo Clinic, Rochester, United States of America
Find articles by Sevits, K. in: PubMed | Google Scholar
1Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, United States of America
2Department of Physiology, Hanyang University, Seoul, Korea, Republic of
3Department of Radiology, Mayo Clinic, Rochester, United States of America
4Department of Quantitative Health Sciences, Mayo Clinic, Rochester, United States of America
5Department of Psychiatry and Psychology, Mayo Clinic, Rochester, United States of America
Find articles by Leija, R. in: PubMed | Google Scholar
1Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, United States of America
2Department of Physiology, Hanyang University, Seoul, Korea, Republic of
3Department of Radiology, Mayo Clinic, Rochester, United States of America
4Department of Quantitative Health Sciences, Mayo Clinic, Rochester, United States of America
5Department of Psychiatry and Psychology, Mayo Clinic, Rochester, United States of America
Find articles by Prabha Kumar, A. in: PubMed | Google Scholar
1Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, United States of America
2Department of Physiology, Hanyang University, Seoul, Korea, Republic of
3Department of Radiology, Mayo Clinic, Rochester, United States of America
4Department of Quantitative Health Sciences, Mayo Clinic, Rochester, United States of America
5Department of Psychiatry and Psychology, Mayo Clinic, Rochester, United States of America
Find articles by Lim, S. in: PubMed | Google Scholar
1Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, United States of America
2Department of Physiology, Hanyang University, Seoul, Korea, Republic of
3Department of Radiology, Mayo Clinic, Rochester, United States of America
4Department of Quantitative Health Sciences, Mayo Clinic, Rochester, United States of America
5Department of Psychiatry and Psychology, Mayo Clinic, Rochester, United States of America
Find articles by Sinhawansa, S. in: PubMed | Google Scholar
1Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, United States of America
2Department of Physiology, Hanyang University, Seoul, Korea, Republic of
3Department of Radiology, Mayo Clinic, Rochester, United States of America
4Department of Quantitative Health Sciences, Mayo Clinic, Rochester, United States of America
5Department of Psychiatry and Psychology, Mayo Clinic, Rochester, United States of America
Find articles by
Carter, R.
in:
PubMed
|
Google Scholar
|
1Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, United States of America
2Department of Physiology, Hanyang University, Seoul, Korea, Republic of
3Department of Radiology, Mayo Clinic, Rochester, United States of America
4Department of Quantitative Health Sciences, Mayo Clinic, Rochester, United States of America
5Department of Psychiatry and Psychology, Mayo Clinic, Rochester, United States of America
Find articles by Stricker, N. in: PubMed | Google Scholar
1Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, United States of America
2Department of Physiology, Hanyang University, Seoul, Korea, Republic of
3Department of Radiology, Mayo Clinic, Rochester, United States of America
4Department of Quantitative Health Sciences, Mayo Clinic, Rochester, United States of America
5Department of Psychiatry and Psychology, Mayo Clinic, Rochester, United States of America
Find articles by Lowe, V. in: PubMed | Google Scholar
1Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, United States of America
2Department of Physiology, Hanyang University, Seoul, Korea, Republic of
3Department of Radiology, Mayo Clinic, Rochester, United States of America
4Department of Quantitative Health Sciences, Mayo Clinic, Rochester, United States of America
5Department of Psychiatry and Psychology, Mayo Clinic, Rochester, United States of America
Find articles by
Port, J.
in:
PubMed
|
Google Scholar
|
1Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, United States of America
2Department of Physiology, Hanyang University, Seoul, Korea, Republic of
3Department of Radiology, Mayo Clinic, Rochester, United States of America
4Department of Quantitative Health Sciences, Mayo Clinic, Rochester, United States of America
5Department of Psychiatry and Psychology, Mayo Clinic, Rochester, United States of America
Find articles by Nair, K. in: PubMed | Google Scholar
Published October 27, 2026 - More info
BACKGROUND. Dementia is a rapidly expanding public health problem with major socio-economic burden. Insulin resistance (IR) is a prevalent but modifiable risk factor for dementia, yet its effects on brain structure, functional connectivity, and metabolism remain incompletely understood.
METHODS. Regional brain glucose uptake (PET), volumes (MRI), functional connectivity (fMRI), and cognition (NIH Toolbox) was measured in 72 adults with or without markers of IR. To evaluate reversibility of IR-associated brain deficits, forty older adults with IR were randomized to forty weeks of metformin or placebo, and brain measures were repeated. As a proof-of-concept experiment, we developed a conditional brain-specific insulin receptor knockout mouse and assessed brain mitochondrial function and cognition.
RESULTS. In older adults with markers of IR is associated with diminished total and regional brain volumes in areas critical for neuronal connectivity, memory, and learning, including cerebral white matter and the hippocampus. Reduced functional connectivity between brain regions detrimental for cognition was also noted. Further, we demonstrated that ATP production, essential for neuronal connectivity, was diminished in neuron-specific insulin receptor knockout mice accompanied by deficits in hippocampal- and prefrontal-dependent tasks. Forty weeks of metformin improved systemic insulin sensitivity concurrent to preserved brain glucose uptake, volume, and functional connectivity within specific regions central to decision-making and learning. Metformin was also associated with an improved composite measure of processing speed and working memory.
CONCLUSION. These findings highlight IR as a key regulator of brain metabolism and support the concept that insulin sensitization can prevent neurobiological deficits in older people with IR.